Phase II-III, factorial multicenter randomized trial evaluating the addition of rofecoxib to polychemotherapy with cisplatin and gemcitabine and the fixed dose rate infusion of gemcitabine in association with cisplatin in the first-line treatment of advanced non-small cell lung cancer

Trial Profile

Phase II-III, factorial multicenter randomized trial evaluating the addition of rofecoxib to polychemotherapy with cisplatin and gemcitabine and the fixed dose rate infusion of gemcitabine in association with cisplatin in the first-line treatment of advanced non-small cell lung cancer

Completed
Phase of Trial: Phase II/III

Latest Information Update: 30 Jun 2007

At a glance

  • Drugs Rofecoxib (Primary) ; Cisplatin; Gemcitabine
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms GECO
  • Most Recent Events

    • 30 Jun 2007 Final results have been published
    • 14 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top